← Back to Patent Explorer
EP0352227A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Modified proteins

Assignee: UCP Gen Pharma AG
•
Filing: 1989-07-11
•
Granted: —
•
Expires: 2009-07-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel polypeptides are provided which differ from desulphatohirudin by simple or multiple mutations. The novel polypeptides have valuable pharmacological properties and can be prepared by recombinant DNA techniques.

Inventors

  • 👤 Stuart R. Dr. Stone
  • 👤 Stanley Dr. Dennis
  • 👤 Jan Dr. Hofsteenge
  • 👤 Bernd Dr. Meyhack
  • 👤 Andrew Dr. Wallace
  • 👤 Hugo Dr. Grossenbacher

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-24 00:17
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/81; C07K14/815; A; A61; A61P; A61P7/00; A61P7/02; A61K; A61K38/00

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 222 words
A process for the production of mutants of desulphatohirudin having the amino acid sequence wherein Y₁ represents Asp or the radical of a neutral genetically encoded amino acid, Y₂ and Y₃ independently from each other represent Glu, Asn or the radical of a lipophilic genetically encoded amino acid, Y₄ and Y₅ independently from each other represent Glu or the radical of a neutral genetically encoded amino acid, Y₆ represents Tyr or the radical of an acidic genetically encoded amino acid and Y₇ represents Gln or the dipeptidyl radical GlnPro, with the exception of compounds of the formula I in which Y₁ is Asp, Y₆ is Tyr, Y₇ is Gln, Y₂ and Y₃ are each Glu and one of the radicals Y₄ and Y₅ is Gln and the other is Glu, and salts thereof, which process comprises culturing a microbial host strain which has been transformed with a hybrid vector comprising an expression cassette consisting of a promoter operably linked to a first DNA sequence encoding a signal peptide linked in the proper reading frame to a second DNA sequence coding for the desulphatohirudin mutant, and a DNA sequence containing transcription termination signals, and isolating the desul­phatohirudin mutant, and, if desired, converting an obtained polypeptide having free carboxy and/or amino groups into a salt or converting a salt obtained into the free compound.
Claim 2
Dependent Claim 222 words
A process for the production of mutants of desulphatohirudin having the amino acid sequence wherein Y₁ represents Asp or the radical of a neutral genetically encoded amino acid, Y₂ and Y₃ independently from each other represent Glu, Asn or the radical of a lipophilic genetically encoded amino acid, Y₄ and Y₅ independently from each other represent Glu or the radical of a neutral genetically encoded amino acid, Y₆ represents Tyr or the radical of an acidic genetically encoded amino acid and Y₇ represents Gln or the dipeptidyl radical GlnPro, with the exception of compounds of the formula I in which Y₁ is Asp, Y₆ is Tyr, Y₇ is Gln, Y₂ and Y₃ are each Glu and one of the radicals Y₄ and Y₅ is Gln and the other is Glu, and salts thereof, which process comprises culturing a microbial host strain which has been transformed with a hybrid vector comprising an expression cassette consisting of a promoter operably linked to a first DNA sequence encoding a signal peptide linked in the proper reading frame to a second DNA sequence coding for the desulphatohirudin mutant, and a DNA sequence containing transcription termination signals, and isolating the desul­phatohirudin mutant, and, if desired, converting an obtained polypeptide having free carboxy and/or amino groups into a salt or converting a salt obtained into the free compound.
Claim 3
Dependent Claim 108 words
A process for the production of desulphatohirudin mutants of the formula I according to claim 1 wherein Y₁ is Asp, Ala, Leu or Asn, Y₂ and Y₃ independently from each other represent Glu, Leu or Asn, Y₄ and Y₅ independently from each other represent Glu, Gln, Asn or Leu, Y₆ is Tyr, Asp or Glu and Y₇ is Gln or the dipeptidyl radical GlnPro, with the exception of compounds of the formula I in which Y₁ is Asp, Y₆ is Tyr, Y₇ is Gln, Y₂ and Y₃ are each Glu and one of the radicals Y₄ and Y₅ is Gln and the other is Glu, and salts thereof.
Claim 4
Dependent Claim 11 words
A process for the production of [Gln⁶¹ʼ⁶²]-desulphatohirudin according to claim 1.
Claim 5
Dependent Claim 11 words
A process for the production of [Leu⁶¹ʼ⁶²]-desulphatohirudin according to claim 1.
Claim 6
Dependent Claim 11 words
A process for the production of [Asn⁶¹ʼ⁶²]-desulphatohirudin according to claim 1.
Claim 7
Dependent Claim 11 words
A process for the production of [Leu⁵⁷ʼ⁵⁸ʼ⁶¹ʼ⁶²]-desulphatohirudin according to claim 1.
Claim 8
Dependent Claim 11 words
A process for the production of [Asn⁵⁷ʼ⁵⁸ʼ⁶¹ʼ⁶²]-desulphatohirudin according to claim 1.
Claim 9
Dependent Claim 11 words
A process for the production of [Ala⁵³]-desulphatohirudin according to claim 1.
Claim 10
Dependent Claim 11 words
A process for the production of [Asp⁶³]-desulphatohirudin according to claim 1.
Claim 11
Dependent Claim 11 words
A process for the production of [Glu⁶³]-desulphatohirudin according to claim 1.
Claim 12
Dependent Claim 11 words
A process for the production of [Pro⁶⁶]-desulphatohirudin according to claim 1.
Claim 13
Dependent Claim 42 words
A process for the production of a pharmaceutical composition which process comprises admixing a desulphatohirudin mutant of the formula I that can be produced in accordance with claim 1, or a pharmaceutically acceptable salt thereof, to a pharmaceutically acceptable carrier and/or adjuncts.
Claim 14
Dependent Claim 134 words
A process for the production of a hybrid vector comprising an expression cassette consisting of a promoter operably linked to a first DNA sequence encoding a signal peptide linked in the proper reading frame to a second DNA sequence coding for the desulphatohirudin mutant that can be produced according to claim 1, and a DNA sequence containing transcription termination signals, which process comprises linking the expression cassette consisting of a promoter operably linked to a first DNA sequence encoding a signal peptide linked in the proper reading frame to a second DNA sequence coding for the desulphatohirudin mutant, and a DNA sequence containing transcription termination signals, or the constituents of the expression cassette to the DNA fragments containing selective genetic markers and origins of replication for the selected microbial host in the predetermined order.
Claim 15
Dependent Claim 82 words
A process for the production of a microbial host strain which has been transformed with a hybrid vector comprising an expression cassette consisting of a yeast promoter operably linked to a first DNA sequence encoding a signal peptide linked in the proper reading frame to a second DNA sequence coding for the desulphatohirudin mutant that can be produced according to claim 1, and a DNA sequence containing transcription termination signals, which process comprises transforming a microbial host strain with said hybrid vector.
Claim 16
Dependent Claim 12 words
A microbial host strain obtainable by the process according to claim 14.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag